AVROBIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of AVROBIO, Inc. - AVROBusiness Wire • 02/14/24
Shareholder Alert: Ademi LLP investigates whether AVROBIO, Inc. has obtained a Fair Price in its transaction with TectonicPRNewsWire • 01/31/24
AVRO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of AVROBIO, Inc. Is Fair to ShareholdersBusiness Wire • 01/30/24
AVROBIO Announces Agreement to Sell Cystinosis Gene Therapy Program for $87.5 MillionBusiness Wire • 05/22/23
AVROBIO Announces Positive Data from Phase 1/2 Clinical Trial of Investigational Gene Therapy for Cystinosis at the ASGCT 26th Annual MeetingBusiness Wire • 05/18/23
AVROBIO Reports First Quarter 2023 Financial Results and Provides Business UpdateBusiness Wire • 05/11/23
AVROBIO Reports Fourth Quarter and Fiscal Year 2022 Financial Results and Provides Business UpdateBusiness Wire • 03/23/23
AVROBIO to Present Clinical and Preclinical Data from Lysosomal Disorder Gene Therapy Pipeline at WORLDSymposium™ 2023Business Wire • 02/09/23
AVROBIO Announces New Positive Clinical Data and Outlines Clinical Development Plan Following Regulatory Discussions for its Gaucher Disease Gene TherapyBusiness Wire • 12/07/22
AVROBIO Reports Third Quarter 2022 Financial Results and Provides Business UpdateBusiness Wire • 11/08/22
AVROBIO to Participate in the Sixth Annual Barclays Gene Editing/Therapy SummitBusiness Wire • 11/07/22